This article is more than 5 years old. Information may no longer be current.
Top 5 articles on fibromyalgia highlight pain, fatigue, disability
Click Here to Manage Email Alerts
Recently published research on fibromyalgia has focused on perceptions about pain and fatigue, and the prevalence of disability among patients with fibromyalgia. Other research highlighted treatment strategies for patients with fibromyalgia and identified subsets of patients who may have varying degrees of symptoms.
Pain and fatigue linked to perception of function in women with fibromyalgia
In a recently published study of women with fibromyalgia, investigators found pain and fatigue explained at least one-third of the variance in patients’ perceived physical performance and function. Read more.
Fast track designation granted by FDA for new fibromyalgia treatment
Innovative Med Concepts LLC announced it has been granted fast track designation by the FDA for the development of its IMC-1 treatment for fibromyalgia, according to a company press release. Read more.
Pressure points, history of trauma cited among key issues in onset, diagnosis of fibromyalgia
Health-related quality of life, tender points and fatigue continue to be key issues in the clinical assessment of patients with fibromyalgia, according to researchers in Spain who noted most patients reported a psychologically stressful event prior to their onset of symptoms and 31% reported a physical event as a trigger. Read more.
Patients with fibromyalgia may have pain improvement with acupuncture
Individualized treatment with acupuncture in a primary care setting provided patients with fibromyalgia with pain relief compared to patients who received a placebo treatment, and the effects were persistent at 1 year, according to researchers in Spain. Read more.
Pregabalin may be effective in reducing pain, improving sleep in patients with fibromyalgia
Pregabalin was effective in reducing pain and improving sleep quality among patients with fibromyalgia through 12 weeks, and adverse effects were consistent with the medication’s known safety profile, according to data published in Current Medical Research and Opinion. Read more.